No signal was created
Signal creation was skipped after analysis.
Aligned runs exist, but none have an executable entry/target/stop plan (level_caps_required=6).
All models highlight a fundamental transformation driven by a blowout Q2 earnings beat ($0.78 EPS vs. $0.41 est) and a 166% YoY revenue surge, supported by a $1.7B Nebius deal and $25B Brookfield financing. Two models emphasize that the recent 11% dip is a temporary profit-taking event in a high-beta name, noting that technical indicators like the 30-minute RSI and MACD are already repairing above $155.87 support. Analysts have responded with aggressive price target hikes to the $290-$346 range, suggesting a mean-reversion bounce toward $194-$210 as the market digests the raised full-year guidance of $3.9B–$4.2B.
All three models agree that BE is experiencing a textbook 'buy the rumor, sell the news' exhaustion gap, with the stock failing to reclaim the $167.03 resistance level despite record results. Technical momentum is deeply bearish across 4-hour and daily timeframes (RSI ~33 and falling), with one model specifically warning of extreme valuation risks (P/E 1707) and dangerous customer concentration (73% of Q2 revenue). Analysts expect further de-risking toward the $156-$159 support cluster or even $120, exacerbated by the stock's high beta (3.74) and looming FOMC macro uncertainty.
Bloom delivered a blowout Q2 (EPS $0.78 vs $0.41 est, revenue +166% YoY) and hiked full-year guidance to ~100% YoY growth, backed by a fresh AI power catalyst (hyperscaler validation, $1.7B Nebius deal, $25B Brookfield financing) and a wave of July 29 analyst upgrades to $290-$346 targets. The -11% move was profit-taking into a high-beta name rather than a fundamental deterioration, and the 30-min tape is already repairing (RSI turning up +7.30, MACD bullish zero-cross) just above 1-day support at $155.87. A swing long targets a mean-reversion bounce back toward the $194 4h resistance zone as the fundamental repricing reasserts over the next 1-3 weeks.
BE just printed a violent -11.34% session and sits at the 1-day resistance shelf ( $167.03) after a parabolic run off the $32.52 low, with all major timeframes bearish (4h/1 day RSI ~33 falling, MACD deeply negative and histograms falling) . A short here targets a mean-reversion drift toward the 4h/1day support cluster near $159 as high-beta (3.74) profit-taking continues into the July 29 FOMC event risk. The stretched valuation (P/E 1707, P/B 58) and single-customer concentration (73% of Q2 revenue) leave the name vulnerable to further de-rating if AI-capex enthusiasm cools.
Bloom Energy gapped down 11% on July 28 despite reporting record revenue ($1.065B, +166% YoY), a massive EPS beat ($0.78 vs $0.41 est), and raising full-year guidance to $3.9B-$4.2B. This is a textbook "buy the rumor, sell the news" exhaustion gap — the stock had already priced in the AI data center demand narrative, and the market is now using the good news to distribute shares. With the stock failing to reclaim the $167 resistance level and momentum deeply bearish on both the 4h and daily timeframes (RSI 33 and falling, MACD histogram accelerating lower), the path of least resistance is lower toward the 4h support at $159 and potentially the 1-day support at $156 as the post-earnings hangover and FOMC uncertainty drive further de-risking.
Bloom Energy's record Q2 earnings (EPS $0.78 vs $0.41 est, revenue +166% YoY to $1.065B) and raised FY2026 guidance ( $3.9B- $4.2B, ~100% YoY growth) confirm an explosive AI-driven demand cycle for its fuel cell technology. The $1.7B Nebius deal and expanded $25B Brookfield financing framework provide concrete visibility into the backlog. The -11% profit-taking selloff on July 28 has driven the stock into oversold territory (4h RSI 33) near the lower Bollinger Band and key support at $159- $165, creating a high-probability mean-reversion entry ahead of what should be continued analyst upgrades and institutional accumulation.
Bloom Energy (BE) presents a compelling long case driven by a powerful earnings catalyst and structural demand for AI power solutions. The company reported record Q2 2026 earnings, doubling estimates with $0.78 EPS and $1.065B revenue (up 166% YoY), while raising full-year guidance to $3.9B–$4.2B, reflecting ~100% YoY growth. The AI power demand narrative is validated by a $1.7B deal with Nebius for AI cloud infrastructure and confirmation that all major U.S. hyperscalers and AI labs have adopted Bloom's onsite power solutions. This fundamental strength is expected to translate into a price recovery toward the $194–$210 range as the market digests the earnings beat and guidance hike, supported by analyst upgrades and bullish price targets.
BE's recent earnings beat and bullish guidance have triggered a classic 'buy the rumor, sell the news' dynamic, exacerbated by extreme overbought conditions and a counter-regime pullback in high-beta stocks. The stock surged post-earnings but is now rejecting key resistance at $167.03 (1-day) and $194.60 (4-hour), with RSI and MACD both showing signs of exhaustion (RSI falling from overbought levels, MACD histogram negative and declining). The FOMC decision looms as a potential catalyst for profit-taking, particularly given BE's high beta (3.74) and the market's rotation away from speculative growth names. The path of least resistance is a retest of support at $155.87, with potential to break lower toward the next demand zone near $120.